Mycovia Pharmaceuticals, Inc.: payments to clinicians
Mycovia Pharmaceuticals, Inc.'s payments to clinicians rose 186% in 2025, to $21,228 across 2 people. Most of it (51%) was consulting fees, then travel and lodging (45%). The largest single recipient (Internal Medicine, Infectious Disease, Michigan) received $13,353.
| Program year | Total | Payments | Clinicians paid |
|---|---|---|---|
| 2025 | $21,228 | 14 | 2 |
| 2024 | $7,418 | 16 | 6 |
Largest recipients in 2025
| # | Clinician | Specialty | Location | Amount |
|---|---|---|---|---|
| 1 | Jack David Sobel, MD | Internal Medicine, Infectious Disease | Detroit, MI | $13,353 |
| 2 | Edwin L. Parsley, D.O. | Internal Medicine, Critical Care Medicine | Houston, TX | $7,875 |
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records